PMID- 16163516 OWN - NLM STAT- MEDLINE DCOM- 20060413 LR - 20181113 IS - 0033-3158 (Print) IS - 0033-3158 (Linking) VI - 183 IP - 2 DP - 2005 Dec TI - Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. PG - 248-56 AB - RATIONALE: Although 3,4-methylenedioxymethamphetamine (MDMA; Ecstasy) has been reported to cause fatal hyperthermia, few studies of the effects of MDMA on core body temperature in humans have been conducted demonstrating increased body temperature. In rats, MDMA causes hyperthermia at warm ambient temperatures but hypothermia at cold ones. OBJECTIVES: In this study, the physiological and subjective effects of MDMA in humans were determined at cold (18 degrees C) and warm (30 degrees C) ambient temperatures in a temperature and humidity-controlled laboratory. METHODS: Ten healthy volunteers who were recreational users of MDMA were recruited. Four laboratory sessions were conducted in a 2x2 design [i.e., two sessions at 30 degrees C and two at 18 degrees C, two during MDMA (2 mg/kg, p.o.) and two during placebo, in double-blind fashion]. Core body temperature (ingested radiotelemetry pill), skin temperature (four weighted sites), heart rate, blood pressure, metabolic rate (indirect calorimetry), shivering (electromyogram levels), and sweat rate (capacitance hygrometry) were measured as well as subjective effects for several time periods following capsule ingestion. RESULTS: MDMA produced significant elevations in core body temperature and metabolic rate in both warm and cold conditions. MDMA also produced significant elevations in blood pressure and heart rate and significantly increased several ratings of subjective effects similar to those previously reported. There were no differences related to ambient temperature for any of the subjective effects, except that ratings of cold and warm were appropriate to the ambient temperature and were not influenced by MDMA. CONCLUSIONS: Unlike findings in rats, MDMA increased core body temperature regardless of ambient temperature in humans. These increases appeared related to increases in metabolic rate, which were substantial. These findings warrant further investigations on the role of MDMA and other stimulants in altering metabolism and thermogenesis. FAU - Freedman, Robert R AU - Freedman RR AD - Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, MI 48201, USA. aa2613@wayne.edu FAU - Johanson, Chris-Ellyn AU - Johanson CE FAU - Tancer, Manuel E AU - Tancer ME LA - eng GR - R01 DA-14874/DA/NIDA NIH HHS/United States PT - Clinical Trial PT - Comparative Study PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20051109 PL - Germany TA - Psychopharmacology (Berl) JT - Psychopharmacology JID - 7608025 RN - 0 (Adrenergic Uptake Inhibitors) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - Adolescent MH - Adrenergic Uptake Inhibitors/*pharmacology MH - Adult MH - Analysis of Variance MH - Blood Pressure/drug effects MH - Body Temperature/*drug effects MH - Body Temperature Regulation/*drug effects MH - Double-Blind Method MH - Electromyography/methods MH - Female MH - Heart Rate/drug effects MH - Humans MH - Male MH - N-Methyl-3,4-methylenedioxyamphetamine/*pharmacology MH - Oxygen Consumption/drug effects MH - Pain Measurement/drug effects MH - Skin Temperature/drug effects MH - Statistics as Topic MH - Telemetry/methods EDAT- 2005/09/16 09:00 MHDA- 2006/04/14 09:00 CRDT- 2005/09/16 09:00 PHST- 2005/05/17 00:00 [received] PHST- 2005/07/18 00:00 [accepted] PHST- 2005/09/16 09:00 [pubmed] PHST- 2006/04/14 09:00 [medline] PHST- 2005/09/16 09:00 [entrez] AID - 10.1007/s00213-005-0149-6 [doi] PST - ppublish SO - Psychopharmacology (Berl). 2005 Dec;183(2):248-56. doi: 10.1007/s00213-005-0149-6. Epub 2005 Nov 9.